万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.resuscitationjournal.com/
https://www.journals.elsevier.com/resuscitation/
3、投稿网址：https://www.editorialmanager.com/RESUS
4、官网邮箱：resus@elsevier.com（编辑部）
5、官网电话：+44 (0)1865 843620（编辑部）
6、期刊刊期：月刊，一年出版12期。
2021年6月7日星期一
投稿须知【官网信息】
Guide for Authors
Resuscitation is a monthly interdisciplinary medical journal and is the official journal of the European Resuscitation Council. All papers are published online-only and deal with the aetiology, pathophysiology and prevention of cardiac arrest, resuscitation training, clinical resuscitation, and rapid response systems. Experimental resuscitation research papers (including animal studies) are published occasionally, but only if they are of exceptional interest and related directly to clinical cardiopulmonary resuscitation. Papers relating to trauma are published occasionally but most of these concern specifically traumatic cardiac arrest. Review articles and Letters to the Editor, particularly relating to articles previously published in Resuscitation, are welcome. We do not publish case reports.
Editorial Policy
The originality of content of papers submitted and the quality of the work on which they are based is the prime consideration of the editors. The paper should deal with original material, neither previously published nor being considered for publication elsewhere, except in special circumstances agreed with the Editor-in-Chief. A few papers are selected for checking with plagiarism software. Papers that are not within the scope of the journal or are far below the standard for publication in Resuscitation will be rejected by the Editors without obtaining peer review. Papers deemed to be within scope and of a sufficient standard are assigned to an editor and sent for peer review; papers may then be returned to authors as accepted, for reconsideration after revision, or rejection. The reviewer's name may or may not be revealed to the author(s), depending on the reviewer's preference. The decision of the Editor-in-Chief regarding acceptance or rejection is final. Resuscitation will occasionally consider protocols for large randomized controlled trials. Such trials will have received substantial grant funding to support their delivery. There is a word limit for all articles as detailed in the table below. Manuscripts will be returned to the author if the word count is exceeded.
WORD LIMIT (excluding abstract and references)
Original Paper* 3000
Short Paper* 1500
Review* 4000
Commentary and Concepts* 2000
Editorial 1200
Letter to Editor 500
TABLES/ILLUSTRATION LIMIT
Original Paper* 6
Short Paper* 4
Review* 10
Commentary and Concepts* 4
Editorial 1
Letter to Editor 1
REFERENCE LIMIT
Original Paper* 80
Short Paper* 40
Review* 100
Commentary and Concepts* 40
Editorial 30
Letter to Editor 10
*option for supplementary online materials
Guide for Authors
These guidelines generally follow the 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals'. The complete document appears at http://www.icmje.org
These instructions can also be found on https://www.journals.elsevier.com/resuscitation/Submission of Papers
Authors must submit their original manuscript and figures online via https://www.editorialmanager.com/RESUS/default.aspx. You will find full instructions located on this site - a Guide for Authors and a Guide for Online Submission. Please follow these guidelines to prepare and upload your article.
Once a manuscript has been uploaded, our system automatically generates an electronic PDF proof, which is used for reviewing. All correspondence, including notification of the Editor's decision and requests for revisions, will be managed via this system. Authors may also track the progress of their paper using this system to final decision. All authors will be sent an e-mail notifying them that the manuscript has been submitted.
If you have any problems submitting your paper through this system, please contact the Editorial Office on: e-mail: resus@elsevier.com; tel: +44 (0)1865 843620; fax: +44 (0)1865 843992.
Upon acceptance of an article, authors will be asked to sign a 'Journal Publishing Agreement' (for more information on this and copyright see https://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript into production together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Once an article has been accepted, the uncorrected provisional pdf will be published immediately online pending publication of the fully formatted final version.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult https://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Please consult https://www.elsevier.com/permissions for further guidelines on permissions.
Your manuscript should be submitted together with a covering letter which should be signed by the corresponding author on behalf of all authors. This letter must include:
* A statement that all authors have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or is the chair of the department who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
* A statement describing any overlap with previous publications and confirmation that the manuscript, including related data, figures and tables, has not been published previously and that the manuscript is not under consideration elsewhere.
* The names and contact addresses (including e-mail) of two potential reviewers who have not been involved in the design, performance and discussion of the data and are not a co-worker. These may or may not be used at the Editor's discretion. You may also mention persons who you would prefer not to review your paper.
Declaration of Conflicts of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. More information.
Role of the Funding Source
All sources of funding must be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state. Please see https://www.elsevier.com/funding
Ethics and Patient Consent
Work on human beings that is submitted to Resuscitation must comply with the principles laid down in the Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript must contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that, where appropriate, subjects gave informed consent to the work. The Ethics/Institutional approval reference number must be included in the paper. Patients have a right to privacy that must not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, must not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
Randomised Controlled Trials
Resuscitation has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research project that assigns human subjects prospectively to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials), and manikin or laboratory studies would be exempt. Further information can be found at http://www.icmje.org.
All randomised controlled trials submitted for publication in Resuscitation should be written to comply with the Consolidated Standards of Reporting Trials (CONSORT) guidelines. Authors must include the CONSORT flow chart and ensure that all elements in the CONSORT checklist are covered. A copy of the CONSORT checklist must be uploaded as supplemental material. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information.
Animal Studies
Animal studies must be reported in accordance with the ARRIVE guidelines (Animals in Research: Reporting In Vivo Experiments) and must include the checklist as supplemental material. A blank form can be downloaded for completion here. An example of a completed checklist can be found at http://www.nc3rs.org.uk/page.asp?id=1357. (The example checklist is based on an original publication by Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 8(6):e1000412. doi:10.1371/journal.pbio.1000412).
The institutional protocol number should be included at the end of the abstract of the article.
Systematic Reviews
Systematic reviews should be reported in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Guidelines (www.prisma-statement.org/) and must include the checklist (https://www.elsevier.com/__data/promis_misc/ISSM_PRISMA_Checklist.pdf) as supplemental material.
Other Study Designs
Other types of study designs should follow the relevant guidance notes for standardized reporting. These can be accessed via the EQUATOR network. http://www.equator-network.org/library/
Structure of Papers
Papers must comply with the word count and figure, table and reference limit listed above.
All papers must include a separate title page documenting: authors' full names, academic and professional affiliations and complete addresses; the name and address of the corresponding author; the word count of the paper and the abstract (if applicable). Professional qualifications are not required to be listed.
Original Papers, Reviews and Short Papers must include an abstract of no longer than 250 words. This should be a structured abstract listing the aim of the study (or review), the methods (or 'data sources' for a review), the results and the conclusion. Commentaries must include a brief abstract of no more than 100 words that summarises the key points.
Papers must be written concisely and conform to the style of Resuscitation. They should be clearly divided into sections: Introduction; Methods; Results; Discussion; Conclusions; Conflicts of Interest; Acknowledgements; References; Legends to figures. For review papers and commentaries use appropriate sub-headings instead of methods, results and discussion.
Letters to the Editor should follow a standard format. They should begin with 'To the Editor,' in italics. Where the letter is a reply to a letter to the editor, please ensure 'Reply to Letter:' is inserted before the title. All letters will be available open access on http://www.resuscitationjournal.com
Language
All papers submitted to the Editor-in-Chief must use 'English' spelling, e.g. haemodynamic, ischaemia, aetiology, oesophagus etc. Use generic names for all drugs. The term 'adrenaline' is preferred to 'epinephrine': for the first use only, 'adrenaline' should be followed by 'epinephrine' in brackets (parentheses). Similar arrangements apply to noradrenaline and norepinephrine.
Resuscitation has an international readership: keep abbreviations to a minimum and confine as much as possible to those in regular use. Too many abbreviations make reading difficult. Abbreviations of units must conform to the International System of Units (SI), for example, kg, g, mg, cm, mm, ml, mg kg-1. Plurals have the same abbreviations as used for the singular. If non-regular abbreviations are used supply a list of these with their definitions as a footnote to page 1. Do not use abbreviations of this type in the abstract.
Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our customer support site (http://support.elsevier.com) for more information.
Supplementary Data (Including Multimedia and Video)
The journal accepts electronic supplementary material to support and enhance your scientific research. Supplementary files allow the author to submit supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more, which will be published online alongside the electronic version of your article. To ensure that your submitted material is directly usable, please provide data in one of the recommended file formats (for detailed guidance on formats for supplementary files go to https://www.elsevier.com/artwork).
更多详情：
https://www.elsevier.com/journals/resuscitation/0300-9572/guide-for-authors
